Abstract
Recent data show that in humans IGF-1 has insulin-like anabolic and growth promoting effects. However, the plasma levels at which IGF-1 exerts these effects differ. IGF-1 plasma levels similar to those in normal children and adults have a growth promoting effect, but higher levels are necessary for IGF-1 to exert insulin-like anabolic effects, and hypoglycemia is a potential risk. Longitudinal bone growth results from the proliferation and differentiation of chondrocytes in epiphyseal cartilage. We present our data from cultured human epiphyseal chondrocytes, which suggest that epiphyseal cartilage may be a target tissue for IGF-1 action during human fetal and postnatal development. © 1993, IEEE. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 257-262 |
| Journal | Journal of Pediatric Endocrinology and Metabolism |
| Volume | 6 |
| Issue number | 3-4 |
| DOIs | |
| Publication status | Published - 1 Jan 1993 |
Fingerprint Dive into the research topics of 'Human Studies on the Biological Actions of IGF-1. Evidence Suggesting that Human Fetal and Postnatal Epiphyseal Cartilage is a Target Tissue for IGF-1 Action'. Together they form a unique fingerprint.
Cite this
Carrascosa, A., & Audí, L. (1993). Human Studies on the Biological Actions of IGF-1. Evidence Suggesting that Human Fetal and Postnatal Epiphyseal Cartilage is a Target Tissue for IGF-1 Action. Journal of Pediatric Endocrinology and Metabolism, 6(3-4), 257-262. https://doi.org/10.1515/JPEM.1993.6.3-4.257